Multiplex Assay Market Global Size, Growth, Trends and Demand with Outlook 2021-2030

The Global Multiplex Assay Market size was valued at USD 77.8 million in 2019, and is predicted to reach USD 153.9 million by 2030, with a CAGR of 6.4% from 2020-2030.

In a multiplex assay test, multiple analytes are simultaneously measured in a single experiment, thereby amplifying multiple targets in a single PCR (Polymerase Chain Reaction). Multiple assay test collects more information in lesser time with minute quantities of proteins, cytokines, biomolecules, and other analytes.

Multiplex assay tests hold wide applications in clinical laboratories, hospitals, pharmaceutical companies, research institutes, and others; for mutation analysis, DNA & RNA detection, pathogen detection, forensic studies, linkage analysis and other such investigations.

Furthermore, the increasing adoption of companion diagnostic systems, are bringing an upsurge in the demand for efficient multiplex assay tests, thereby supplementing the growth of multiplex assay market.

Access Full Description of this report at:-

https://www.nextmsc.com/report/multiplex-assay-market

Competitive Landscape

The multiplex assay market is highly competitive and consists of various market players. Some of the major market players include Thermo Fisher Scientific Inc., Luminex Corporation, Bio-Rad Laboratories Inc., Illumina Inc., Becton, Dickinson and Company, QIAGEN N.V., Seegene Inc., Abcam PLC, Randox Laboratories Ltd., and Meso Scale Diagnostics LLC, among others.

The market players are contributing their part in saving the world from the COVID-19 pandemic, by undergoing various R&D activities to carry-out clinical researches, and to develop and deploy new products that can assist in fighting the novel corona virus. Moreover, increasing number of Food and Drug Administration (FDA) approvals further stimulates the growth of multiplex assay market.

In April 2020, Bio-Rad Laboratories Inc., one of the major players in the global multiplex assay market, announced that it has received the Emergency Use Authorization by the U.S FDA for its Droplet Digital PCR (ddPCR) SARS-CoV-2 Test Kit that runs on Bio-Rad's QX200 and QXDx ddPCR systems. Due to high sensitivity of this test it is well-suited for screening upper respiratory track samples in patients either in the early stage of infection, having lower viral load, or in patients recovering from the infection. Hence, it offers higher efficiency and accuracy of the result, as compared to conventional PCR tests.

Also, in the same month, Bio-Rad Laboratories, Inc., announced the launch of ‘Serology Assay,’ a blood-based immunoassay kit, formulated to identify antibodies to the virus associated with COVID-19 pandemic, the SARS-CoV-2. Of the 700 samples detected by this test, 99% success result have been achieved.

Moreover, in March 2020, Thermo Fisher Scientific, one of the major players in the global multiplex assay market, announced the launch of its five new Thermo Scientific SureTect PCR Assay test kits, along with an updated software to test food and related samples. These test kits are used for investigating presence of Cronobacter species, Listeria species, Listeria monocytogenes, Salmonella species, Salmonella Enteritidis, and Salmonella Typhimurium, in food products and consumables. As compared to conventional PCR tests that takes 9 days to give results, the Thermo Scientific SureTect PCR Assay test delivers result in just 24 hours, providing multiplex assay capability up to six STEC targets; hence it is advantageous for commercial testing.

Request sample copy of this report at:-

https://www.nextmsc.com/multiplex-assay-market/request-sample

Market Segmentations and Scope of the Study:

The global multiplex assay market share has been analyzed based on product, type, technology, application, end user and geography.

Based on product, the market is segmented into multiplex assay reagents & consumables, multiplex assay instruments & accessories, and multiplex assay software & services. Based on type, the market is fragmented into nucleic acid-based multiplex assays, protein-based multiplex assays, and others. Based on technology, the market is categorized into Multiplex PCR, Multiplex Protein Microarray, and others. Based on application, the market is divided into Companion Diagnostics, Research & Development, and Clinical Diagnostics. Based on end user, the market is divided into hospitals, clinical laboratories, research institutes, and pharmaceuticals & biotechnological companies. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America is expected to retain its dominance in terms of market share over the forecast period owing to the increased adoption of multiplex assay. The other factors such as increase in technological advancement, presence of developed healthcare infrastructures, and increased prevalence of various chronic disorders, are likely to promote the growth of multiplex assay market in this region.

Asia Pacific is expected to show tremendous growth with increasing market share over the forecast period owing to the upsurge in the adoption of companion diagnostics. Furthermore, increased adoption of advanced technology, soaring demand for safe and effective treatment options, as well as new product launches, are expected to fuel the growth of multiplex assay market in this region.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.